I was thinking this before you posted, but it woul
Post# of 148187
(Total Views: 357)
Posted On: 09/04/2019 10:28:17 AM
I was thinking this before you posted, but it would be interesting to see if current patients (preferably mono patients or combo patients not using toxic drugs) have NASH, liver fibrosis, metastatic cancer, or other CCR5-linked diseases?
I agree with you other than combo and mono is mostly not that involved right now (combo needs BLA filed and mono pending FDA approval) so why not get future indications teed up and ready for trials at relatively low costs? I don't think CYDY intends to initiate these trials unless a BP is paying for them or our financing concerns are resolved.
I agree with you other than combo and mono is mostly not that involved right now (combo needs BLA filed and mono pending FDA approval) so why not get future indications teed up and ready for trials at relatively low costs? I don't think CYDY intends to initiate these trials unless a BP is paying for them or our financing concerns are resolved.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼